Management of Benzodiazepine Withdrawal in the Outpatient and Non-Hospital Settings

Sunday, April 27, 2025

8:30 AM – 9:45 AM

Presenter(s)

Robert Cole Pueringer, MD

Medical Toxicologist, Addiction Medicine Specialist, Hospitalist
Essentia Health
Duluth, Minnesota
Timothy J. Wiegand, MD, FACMT, FAACT, DFASAM

Director of Addiction Medicine Department of Emergency Medicine
Strong Memorial Hospital
University of Rochester School of Medicine & Dentistry
Rochester, New York
JoAn Laes, MD

Addiction Physician
Hazelden Betty Ford Foundation
Roseville, Minnesota
Soumya L. Pandalai, MD, DFASAM

Medical Director, Addiction Medicine Specialist
Brightview Health
Westerville, Ohio

Non-presenting author(s)

Emily Brunner, MD, DFASAM

Addiction Medicine Specialist
Gateway Recovery, Hazelden Betty Ford Foundation
Minneapolis, Minnesota

This advanced case-based focus session will improve understanding of benzodiazepine use disorder, the pathophysiology of benzodiazepine withdrawal, and the management of benzodiazepine withdrawal using different pharmacotherapies, regimens, and management strategies in the outpatient and non-hospital setting.

Learning Objectives:

Learners will be able to:

Compare and contrast the use of GABAergic and non-GABAergic agents for the treatment of benzodiazepine withdrawal in outpatient and nonhospital-based settings.
Describe the evaluation of patient clinical characteristics to determine appropriateness for outpatient benzodiazepine withdrawal management.
Understand the risks and benefits of various withdrawal regimens for management of benzodiazepine withdrawal.

Disclosure(s):

Robert Cole Pueringer, MD: No financial relationships to disclose

Timothy J. Wiegand, MD, FACMT, FAACT, DFASAM: No financial relationships to disclose

JoAn Laes, MD: No financial relationships to disclose

Soumya L. Pandalai, MD DFASAM: No financial relationships to disclose